Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]

Ítems similars

• Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
  per: Kamijima, Kunitoshi, et al.
  Publicat: (2013)
• Randomized, double‐blind, placebo‐controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder
  per: Inoue, Takeshi, et al.
  Publicat: (2019)
• Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
  Publicat: (2013)
• Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response [Corrigendum]
  Publicat: (2014)
• Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial
  per: WANG, Zhiyang, et al.
  Publicat: (2015)